Health Care/Hospital
Cistto Launches the "Humanized Anti-Aging Global Scientist Alliance" in China, Empowering Products with Cutting-Edge Science
LOS ANGELES, Nov. 25, 2024 /PRNewswire/ -- As an emerging brand specializing in sensitive skin repair, Cistto is grounded in skin science and committed to advancing skin health through the latest dermatological breakthroughs and cutting-edge biotechnology. Cistto is steadfast in its promise to de...
Food Allergy: LongBio's LP-003 achieves its fourth IND approval
SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- LongBio is proud to announce that the National Medical Products Administration (NMPA,China) has approved the Investigational New Drug (IND) application for LP-003, the company's next-generation anti-IgE antibody, to begin a clinical trial for the treatment ...
Lunit to Showcase Research Contributions at RSNA 2024 with Record-Breaking 20 Abstracts
Twenty studies validate AI performance across diverse populations and clinical settings, including award-winning research in emergency radiology SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeu...
Neurophet Secures FDA 510(k) Clearance for Multiple Sclerosis Analysis with 'Neurophet AQUA'
* New features include advanced analysis of multiple sclerosis (MS) and white matter hyperintensities alongside brain atrophy analysis * Accelerating global expansion with cutting-edge technology targeting MS, a prevalent condition inNorth America and Europe. SEOUL, South Korea, Nov. 25, 2024...
Lakeside Strengthens Market Position in China's Pharmaceutical Logistics with Key Sinopharm(Hubei) Contracts
ITASCA, Ill., Nov. 25, 2024 /PRNewswire/ -- Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH), a U.S.-based integrated cross-border supply chain solution provider with a strategic focus on the Asian market operating under the brand American Bear Logistics ("ABL"), announces th...
LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System
Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings * Replaces time-consuming manual spot checking with continuous, near real-time active patient monitoring * Web-based system displays mult...
HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals Announce Successful Completion of a First-in-Human Study for Potential Disease-Modifying Therapy for Parkinson's Disease
* HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. * No serious treatment related adverse events were reported and such findings were proportional between placebo and dosed groups. * PK results support once a day dosing. ROCKVILLE, Md. and SEOUL,...
AIA Hong Kong & Macau launches OptimaCEO Medical Plan
Revolutionary, prestigious medical and wellness solutions help high-end customers and their families achieve longer healthspans * Introduces brand-new infinite health programmes and the rare-in-market Wellness Relationship Manager * Comprises over 500 medical specialists and healthcare profes...
Grand Opening of the Second CREATE Symposium, Exploring New Directions in Smart Healthcare
HONG KONG, Nov. 25, 2024 /PRNewswire/ -- In an era driven by artificial intelligence (AI), the deep integration of advanced technologies into healthcare has become an unstoppable trend. These innovations are reshaping the industry, accelerating transformation, and driving unprecedented breakthrou...
Smartee Introduces Facial Convexity and Deviation Solutions in Vietnam
HO CHI MINH CITY, Vietnam, Nov. 25, 2024 /PRNewswire/ -- The 4th Scientific Meeting of the Ho Chi Minh City Association of Orthodontists recently took place at The Reverie Saigon Hotel inVietnam. The theme was "Orthodontic Management of Growing Patients." Over 400 doctors attended to exchange ind...
Veeva Announces AI in Vault CRM
CRM Bot and Voice Control deliver GenAI-powered assistance in Vault CRM
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- Veeva Systems
Hanmi Pharmaceutical and Beijing Hanmi Progress Clinical Trials of Co-developed BH3120 as a Next-Generation Cancer Immunotherapy
Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S. Phase 1 trial is progressing smoothly, with no dose-limiting toxicity observed Phase 1 trial evaluating the combination of BH3120 and MSD's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab) un...
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
ROCKVILLE, Md. and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has appointed M...
Innovent to Present Clinical Data of Multiple Novel Molecules at ESMO Asia 2024
SAN FRANCISCO and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune...
Novo AI's Solution Boosts APRIL International's Efficiency by 400%
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- In just a few months, Novo AI's advanced solution haselevated APRIL International's performance across Thailand, Vietnam, Hong Kong, and Singapore, achieving more than three fold increase in efficiency and setting new benchmarks in private medical insurance...
ArkBio Announces Successful Completion of Enrollment and Dosing for Phase 1 Clinical Study of AK0610, a Preventive Antibody Against Respiratory Syncytial Virus Infection
SHANGHAI, Nov. 25, 2024 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced today the successful enrollment and dosing of all participants in a Phase 1 clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus (RSV) infec...
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its Phase 1 trial of SCG101, a first-in-class autolog...
Hankyung.com introduces: MecKare, Leading the AI-powered Innovation in Health Monitoring Solution
- Leading efficient care management for the elderly with unimpeded smartcare
https://img.hankyung.com/pdsdata/pr.hankyung.com/uploads/2024/11/image01-1.png
Boehringer Ingelheim launches VETMEDIN® Solution (pimobendan oral solution), first oral solution approved by the FDA for congestive heart failure in dogs
* Heart disease in dogs is almost as common as it is in humans, affecting approximately 10 percent of dogs in their lifetime1 * Previous studies have shown that VETMEDIN® could help improve the survival time and quality of life for dogs with congestive heart failure due to myxomatous mitral v...
The Perfect Black Friday Treat: Fitking Massage Devices for Active Lifestyles
NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Black Friday is here, and there's no better time to prioritize your post-workout recovery and relaxation. Whether you're looking to treat yourself or find the perfect gift for fitness enthusiasts, Fitking's innovative massage devices are tailored to help so...
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 292 media titles]
2025-01-14 21:00Gen Z Travelers Drive Buy Now, Plan Later Travel Bookings by Over 20%: Fliggy's 2024 Buy Now Plan Later Travel Insight
[Picked up by 286 media titles]
2025-01-10 16:04VANTAGE FOUNDATION SUPPORTS GRAB INDONESIA IN EMPOWERING WOMEN DRIVER-PARTNER
[Picked up by 280 media titles]
2025-01-09 18:26